President, Senior Partner & European Patent Attorney at Ström & Gulliksson
Education: M.Sc. in Chemical Engineering, Lund Institute of Technology.
Experience: Specialized in intellectual property rights, such as patent, trademark, design, and copyright law. Vastly experienced in patent issues, such as prosecution, opposition and appeal proceedings, on a multinational level, as well as court proceedings, and specifically within the technical field of medical devices. Additionally, he has been involved in taking seed companies through investment mile stones and stock market introductions, and is an active business angel and fund raiser. Rikard was Elected among Sweden's top 101 Super Talents 2013 by business magazine Veckans Affärer.
M.Sc. in Chemical Engineering, Chalmers University of Technology.
Experience: Over 25 years in international business/management. Former CEO of several companies, for example the Perstorp Group and former partner in leading Private Equity firm PAI Partners. Today, he holds several non-executive board positions among which he is Chairman of the Board of the BillerudKorsnäs group, Vigmed AB, Nexam Chemical AB and Vida AB. In addition he acts as a business angel active with investments in technology start-up companies.
Specific board focus: Corporate Governance, Financing and Investor relations.
Board Member, Senior Partner & European Patent Attorney at Ström & Gulliksson
Education: M.Sc. in Computer Engineering, Lund Institute of Technology.
Experience: Practicing in intellectual property rights, such as patent, trademark, design, and copyright law, since more than 20 years. Specializes in patent prosecution, opposition & appeal and litigation. Additional focus areas are licensing & tech transfer, IP strategies and IP commercialization. Björn is a business angel and fund raiser.
World leading expert in the area of CMC statistics with 20+ years of broad experience in all aspects of development, registration and manufacturing of inhalation products (DPI, MDI, nasal sprays and nebulizing products). Since 2010 owner of "S5 Consulting" that provides expert statistical support and general development and strategic advice in particular to innovator and generic companies with interest in inhalation products. Previously Principal Scientist at AstraZeneca, Associate Director Non-Clinical Statistic at Amgen and Head of Regulatory Affairs & Project Management at Siegfried Pharma Development. Currently adjunct professor at the Department of Pharmaceutics, University of Florida, and member of the United States Pharmacopeia Statistics Expert Committee. Specialties: Statistical planning, DoE, evaluation and presentation related to device & formulation development, in-vitro bioequivalence, analytical methods, method transfer, specifications & shelf-life, IVIVC, regulatory submissions, statistical process control, validations, modelling and simulation, technical writing.
M. Sc. Mechanical Engineering
Inhalation device expert with 35+ years broad experience from development and industrialization of pharmacetical and medical device, including 6 years of global business development within inhalation devices. Previously Associate Director Product Development and Head of Device Development at AstraZeneca in UK and Sweden. Co-inventor of Turbulaler© and responsible for the development and industrialization of Turbuhaler© device and for the development and documentation of a number of devices covering pMDIs, DPIs, SVNs and spacer devices.
Sr Business Development Manager at B&O Medicom for 6 years with global responsibility for inhalation business including management of late stage industrialization inhaler project.
Since 2014 supporting the industry as independant consultant in questions related to strategy, development and industrialization of inhalation devices.
PhD Analytical Chemistry
Deep and broad knowledge in inhaled medication development, where creativity and cross-functional work skills are distinguishing features. Currently Senior Inhalation Consultant at Emmace Consulting AB. Previously Team Leader and Associate Principle Scientist at AstraZeneca Pharmaceutical and Analytical Development for 29 years. Long experience from developing new formulations and device platforms, as well as inhalation products for the market. Excellent skills in developing and adapting aerosol characterization technologies, manual and automatic, for mainly, but not only, dry powder inhalers, including In vivo-In vitro Correlation (IVIVC) methodology for lung dose prediction. Advising project teams strategically and regulatory during development and registration phases, including technical writing. Has been an active member in industrial consortia like EPAG and IPAC-RS, as well as a pharmacopeial working member of Ph Eur inhalanda Working Party.